![Carl Ernst Plesser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Carl Ernst Plesser
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Future Capital
![]() Future Capital Investment ManagersFinance Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany.
1
| Subsidiary | Investment Managers | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Carl Ernst Plesser tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Ludwig-Maximilians-Universität München | College/University | Masters Business Admin | |
CEVEC Pharmaceuticals GmbH
![]() CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Creathor Venture Management GmbH
![]() Creathor Venture Management GmbH Investment ManagersFinance Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions. | Investment Managers | Private Equity Investor | |
Blueprint Genetics Oy
![]() Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Director/Board Member | |
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Germania | 5 |
Stati Uniti | 2 |
Finlandia | 2 |
Settori
Health Technology | 4 |
Technology Services | 2 |
Consumer Services | 2 |
Finance | 2 |
Posizioni
Director/Board Member | 5 |
Private Equity Investor | 2 |
Chief Executive Officer | 1 |
Masters Business Admin | 1 |
Contatti più connessi
Insiders | |
---|---|
Christian Leikert | 7 |
- Borsa valori
- Insiders
- Carl Ernst Plesser
- Connessioni Società